Rafferty Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Rafferty Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,997	Closed	-$138K	–	1096
2025 Q1	$138K	Buy	+31,997	New	+$129K	﹤0.01%	1040
2022 Q3	–	Sell	-225,075	Closed	-$1.1M	–	1216
2022 Q2	$1.1M	Sell	225,075 -9,730	-4%	-$59.9K	0.01%	615
2022 Q1	$1.79M	Sell	234,805 -148,665	-39%	-$1.15M	0.01%	640
2021 Q4	$3.54M	Buy	383,470 +234,312	+157%	+$2.49M	0.02%	500
2021 Q3	$2.12M	Sell	149,158 -23,360	-14%	-$363K	0.01%	627
2021 Q2	$2.87M	Buy	+172,518	New	+$3.22M	0.02%	516

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management's ORGO Position: Q2 2025 in Review

Rafferty Asset Management sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 31,997 shares — an estimated $138K sold.

Rafferty Asset Management first reported a position in ORGO in Q2 2021 and held it in 6 quarters. The position peaked at $3.54M in Q4 2021. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

Rafferty Asset Management reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
Rafferty Asset Management sold 31,997 Organogenesis Holdings shares in Q2 2025, an estimated $138K.
Rafferty Asset Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 6 quarters.
Rafferty Asset Management's Organogenesis Holdings position peaked at $3.54M in Q4 2021.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Rafferty Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.